128 related articles for article (PubMed ID: 17596270)
1. Transforming growth factor-beta as a differentiating factor for cultured smooth muscle cells.
Gawaziuk JP; X ; Sheikh F; Cheng ZQ; Cattini PA; Stephens NL
Eur Respir J; 2007 Oct; 30(4):643-52. PubMed ID: 17596270
[TBL] [Abstract][Full Text] [Related]
2. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
3. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
Kuemmerle JF; Murthy KS; Bowers JG
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts.
Petridou S; Maltseva O; Spanakis S; Masur SK
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):89-95. PubMed ID: 10634606
[TBL] [Abstract][Full Text] [Related]
5. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
Li X; McFarland DC; Velleman SG
Domest Anim Endocrinol; 2008 Oct; 35(3):263-73. PubMed ID: 18650056
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
9. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
Budasz-Rwiderska M; Jank M; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
[TBL] [Abstract][Full Text] [Related]
13. Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β.
Groenendijk BC; Benus GF; Klous A; Pacheco YM; Volger OL; Fledderus JO; Ferreira V; Engelse MA; Pannekoek H; ten Dijke P; Horrevoets AJ; de Vries CJ
Exp Cell Res; 2011 Jan; 317(2):131-42. PubMed ID: 20955695
[TBL] [Abstract][Full Text] [Related]
14. Adipose stromal cells differentiate along a smooth muscle lineage pathway upon endothelial cell contact via induction of activin A.
Merfeld-Clauss S; Lupov IP; Lu H; Feng D; Compton-Craig P; March KL; Traktuev DO
Circ Res; 2014 Oct; 115(9):800-9. PubMed ID: 25114097
[TBL] [Abstract][Full Text] [Related]
15. A novel aptamer targeting TGF-β receptor II inhibits transdifferentiation of human tenon's fibroblasts into myofibroblast.
Zhu X; Li L; Zou L; Zhu X; Xian G; Li H; Tan Y; Xie L
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6897-903. PubMed ID: 22899759
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line.
Chen S; Lechleider RJ
Circ Res; 2004 May; 94(9):1195-202. PubMed ID: 15059931
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells.
Ninomiya K; Takahashi A; Fujioka Y; Ishikawa Y; Yokoyama M
Hypertens Res; 2006 Apr; 29(4):269-76. PubMed ID: 16778334
[TBL] [Abstract][Full Text] [Related]
18. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression.
Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A
Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762
[TBL] [Abstract][Full Text] [Related]
19. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.
Rezaei HB; Kamato D; Ansari G; Osman N; Little PJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):661-7. PubMed ID: 21883378
[TBL] [Abstract][Full Text] [Related]
20. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
